Global Trocars Market - 2024-2031

Market Overview

The Global Trocars Market reached US$ 725.45 million in 2023 and is expected to reach US$ 1,095.56 million by 2031, growing at a CAGR of 5.4% during the forecast period 2024-2031.

Trocars are vital medical devices used in laparoscopic surgery, enabling minimal invasive access to the abdominal cavity. They have evolved from reusable to sterile and disposable versions, enhancing safety and ease of use for surgeons and patients. Trocars consist of an awl, cannula, and seal, serving as portals for endoscopic instruments, enabling faster recovery and reduced scarring compared to traditional open surgeries.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of chronic diseases

The burden of chronic diseases such as diabetes, cardiovascular diseases, and obesity is rapidly increasing around the world. These chronic diseases are affecting a large proportion of the population and thus increasing the number of surgical procedures across the world.

For instance, according to the World Health Organisation, in 2022, 2.5 billion adults (18 years and older) were overweight. Of these, 890 million were living with obesity. In 2022, 43% of adults aged 18 years and over were overweight and 16% were living with obesity.

In 2022, an estimated 37 million children under the age of 5 years were overweight. Once considered a high-income country problem, overweight is on the rise in low- and middle-income countries. In Africa, the number of overweight children under 5 years has increased by nearly 23% since 2000.

Complications associated with the use of trocars

Immediate complications include vascular damage, bowel/visceral damage, subcutaneous emphysema, air embolus, and difficulty entering the peritoneal cavity. Bowel and vascular damage are frequently caused by the blind placement of the main trocar or veress needle. However, subsequent trocar insertion might result in damage if the trocars are not correctly visualized during their insertion.

Segment Analysis

The global trocars market is segmented based on product type, application end-user and region.

The disposable trocars from the product type segment accounted for approximately 38.3% of the trocars market share

The disposable trocars from the product type segment accounted for approximately 38.3%. The disposable trocars segment is expected to be the dominant product type in the market due to its growing importance in laparoscopic surgery and diagnostic laparoscopy. These disposable trocars are used as access ports for inserting cameras into the abdominal cavity, maintaining sterility, reducing infection risk, and requiring no reprocessing.

Moreover, Disposable trocars streamline surgical workflows by eliminating the need for instrument reprocessing and sterilization cycles. They save time and resources, enabling faster case turnover and optimizing operating room utilization. The convenience of disposable trocars enhances procedural efficiency and throughput, thereby enhancing surgical productivity and patient throughput.

Geographical Analysis

North America is estimated to hold about 43.2% of the total market share throughout the forecast period

North America is estimated to hold about 43.2% of the total market share throughout the forecast period owing to factors like, novel product launches, advancement in trocars, FDA approvals. Also, a rise in the prevalence of chronic diseases, rise in minimally invasive surgeries in the region help the overall region to grow during the forecast period.

For instance, in December 2023, Canada-based company Xpan received US Food and Drug Administration (FDA) 510(k) clearance for its universal trocar system. Xpan's universal trocar system starts as a 3mm port and can be expanded to 5mm or 12mm during the procedure, offering flexibility to surgeons. The radial dilation minimizes tissue disruption compared to cutting.

Covid 19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the use of surgical trocars, which are essential instruments for laparoscopic and minimally invasive procedures. Moreover, the COVID-19 pandemic has led to an increased demand for disposable trocars. This is likely due to the need to minimize the risk of virus transmission during surgical procedures, as trocars can potentially generate aerosols that could spread the virus.

Competitive Landscape

The major global players in the market include Conmed Corporation, The Cooper Companies Inc, Teleflex Incorporated, Medtronic Plc, B. Braun Medical Inc., JOHNSON & JOHNSON, Laprosurge, Purple Surgical, Applied Medical Resources Corporation, Peters Surgical among others.

Key Developments

• In March 2022, EVA NEXUS introduced multiple innovations in surgical performance and efficiency including SmartIOP combines with the existing EquiPhaco technology for optimized control in cataract surgery, EVA AVETA a ground-breaking trocar cannula system and EVA INICIO, the first approved micro-injection system.
• In September 2022, AFS MEDICAL GmbH launched a new product in the trocars line, LEXION AP 50/30. Its main specifications are an entirely closed system, continuous tissue moistening caused by permanent c02 heating, and constant pneumoperitoneum.

Why Purchase the Report?

• To visualize the global trocars market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• identify commercial opportunities by analyzing trends and co-development.
• excel data sheet with numerous data points of the trocars market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global trocars market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies